Table 3. Cerenkov Luminescence measurements of the study group (n=7) grouped to positive surgical margins (n=3) and negative surgical margins (n=4).
Data of the study group (n=7) | CLI Data without 550-nm short-pass filter | CLI Data with 550-nm short-pass filter | P value |
---|---|---|---|
Median prostate background, photons/s/cm2/sr (IQR) | 2,392.00 (1,849.17; 6,150.75) | 1,465.50 (1,373.00; 1,776.08) | 0.018 |
Median TBR with PSM (IQR) | 3.33 (2.79; 5.73) | 2.10 (1.50; 2.15) | Not significant |
Median TBR without PSM (IQR) | 3.61 (2.95; 11.77) | 1.11 (1.09; 1.47) | Not significant |
Median CNR with PSM (IQR) | 14.98 (11.73; 16.20) | 6.54 (2.44; 6.71) | Not significant |
Median CNR without PSM (IQR) | 11.16 (9.83; 178.31) | 0.56 (0.50; 3.58) | Not significant |
TBR and CNR are stated as median values (IQR). CLI, Cerenkov Luminescence Imaging; CNR, contrast to noise ratio; IQR, interquartile ranges; PSM, positive surgical margin; TBR, tumor to background ratio.